TCL Archive Diet Supplements Should Be Held To Scientific Standards, Broder Tells House August 6, 1993
TCL Archive Building Boom of Proton Beam Centers Flares Up in Washington and Baltimore October 25, 2013
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
